Managing cardiovascular risk factors in patients with chronic kidney disease: pharmacological and non-pharmacological interventions in the Copenhagen CKD Cohort
Ellen Linnea Freese Ballegaard, 1,2, Nicholas Carlson, 1, Morten Buus Jørgensen, 1, Ida Maria Hjelm Sørensen, 1, Helene Trankjær, 1, Anna Birna Almarsdóttir, 3, Susanne Bro, 1, Bo Feldt-Rasmussen, 1,2, Anne-Lise Kamper for The Copenhagen CKD Cohort Study Group 1
1 Department of Nephrology, Rigshospitalet, University of Copenhagen, Denmark
2 Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark
3 Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
Correspondence to: Ellen Linnea Freese Ballegaard; E-mail: ellen.linnea.freese.ballegaard@regionh.dk
Abstract
Background Although cardiovascular morbidity and mortality are substantial in patients with chronic kidney disease (CKD), guideline-directed treatment of cardiovascular risk factors remains a challenge.
Methods Observational, cross-sectional study including patients aged 30–75 years with CKD stage 1–5 without kidney replacement therapy from a tertiary hospital outpatient clinic. Data was obtained through patient interview, clinical examination,...
